Annual SG&A
$656.64 M
+$40.33 M+6.54%
31 December 2023
Summary:
Integra LifeSciences Holdings annual selling, general & administrative expenses is currently $656.64 million, with the most recent change of +$40.33 million (+6.54%) on 31 December 2023. During the last 3 years, it has risen by +$62.12 million (+10.45%). IART annual SG&A is now -4.94% below its all-time high of $690.75 million, reached on 31 December 2018.IART Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$177.19 M
-$18.28 M-9.35%
30 September 2024
Summary:
Integra LifeSciences Holdings quarterly selling, general & administrative expenses is currently $177.19 million, with the most recent change of -$18.28 million (-9.35%) on 30 September 2024. Over the past year, it has increased by +$15.24 million (+9.41%). IART quarterly SG&A is now -9.35% below its all-time high of $195.47 million, reached on 30 June 2024.IART Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$3.74 B
-$6.54 M-0.17%
30 September 2024
Summary:
Integra LifeSciences Holdings TTM selling, general & administrative expenses is currently $3.74 billion, with the most recent change of -$6.54 million (-0.17%) on 30 September 2024. Over the past year, it has increased by +$3.10 billion (+479.78%). IART TTM SG&A is now -0.17% below its all-time high of $704.16 million, reached on 30 September 2018.IART TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IART Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.5% | +9.4% | +479.8% |
| 3 y3 years | +10.4% | +13.6% | +486.9% |
| 5 y5 years | -4.9% | +2.4% | +441.9% |
IART Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +10.4% | -9.3% | +23.2% | -0.2% | +57.9% |
| 5 y | 5 years | -4.9% | +10.4% | -9.3% | +52.6% | -0.2% | +145.6% |
| alltime | all time | -4.9% | >+9999.0% | -9.3% | >+9999.0% | -0.2% | +1018.0% |
Integra LifeSciences Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $177.19 M(-9.4%) | $701.59 M(+2.2%) |
| June 2024 | - | $195.47 M(+17.9%) | $686.35 M(+4.7%) |
| Mar 2024 | - | $165.80 M(+1.6%) | $655.78 M(-0.1%) |
| Dec 2023 | $656.64 M(+6.5%) | $163.13 M(+0.7%) | $656.64 M(+1.7%) |
| Sept 2023 | - | $161.95 M(-1.8%) | $645.43 M(+2.9%) |
| June 2023 | - | $164.91 M(-1.0%) | $627.30 M(+0.7%) |
| Mar 2023 | - | $166.66 M(+9.7%) | $623.05 M(+1.1%) |
| Dec 2022 | $616.32 M(-3.3%) | $151.92 M(+5.6%) | $616.32 M(-1.6%) |
| Sept 2022 | - | $143.82 M(-10.5%) | $626.65 M(-1.9%) |
| June 2022 | - | $160.65 M(+0.5%) | $638.84 M(-0.3%) |
| Mar 2022 | - | $159.93 M(-1.4%) | $640.74 M(+0.5%) |
| Dec 2021 | $637.45 M(+7.2%) | $162.25 M(+4.0%) | $637.45 M(-0.0%) |
| Sept 2021 | - | $156.01 M(-4.0%) | $637.59 M(+0.9%) |
| June 2021 | - | $162.55 M(+3.8%) | $631.65 M(+7.9%) |
| Mar 2021 | - | $156.63 M(-3.5%) | $585.21 M(-1.6%) |
| Dec 2020 | $594.53 M(-13.5%) | $162.39 M(+8.2%) | $594.53 M(-2.0%) |
| Sept 2020 | - | $150.08 M(+29.3%) | $606.39 M(-3.7%) |
| June 2020 | - | $116.11 M(-30.0%) | $629.41 M(-7.3%) |
| Mar 2020 | - | $165.95 M(-4.8%) | $678.68 M(-1.3%) |
| Dec 2019 | $687.60 M(-0.5%) | $174.25 M(+0.7%) | $687.60 M(-0.4%) |
| Sept 2019 | - | $173.10 M(+4.7%) | $690.57 M(-0.0%) |
| June 2019 | - | $165.38 M(-5.4%) | $690.83 M(-1.6%) |
| Mar 2019 | - | $174.87 M(-1.3%) | $702.05 M(+1.6%) |
| Dec 2018 | $690.75 M(+10.7%) | $177.23 M(+2.2%) | $690.75 M(-1.9%) |
| Sept 2018 | - | $173.35 M(-1.8%) | $704.16 M(+4.1%) |
| June 2018 | - | $176.60 M(+8.0%) | $676.75 M(+4.9%) |
| Mar 2018 | - | $163.57 M(-14.2%) | $645.16 M(+3.4%) |
| Dec 2017 | $624.10 M(+37.0%) | $190.64 M(+30.6%) | $624.10 M(+14.4%) |
| Sept 2017 | - | $145.94 M(+0.6%) | $545.58 M(+6.6%) |
| June 2017 | - | $145.01 M(+1.8%) | $511.95 M(+5.3%) |
| Mar 2017 | - | $142.50 M(+27.1%) | $486.15 M(+6.7%) |
| Dec 2016 | $455.63 M(+9.6%) | $112.12 M(-0.2%) | $455.63 M(+0.5%) |
| Sept 2016 | - | $112.32 M(-5.8%) | $453.26 M(-0.2%) |
| June 2016 | - | $119.22 M(+6.5%) | $454.37 M(+4.6%) |
| Mar 2016 | - | $111.97 M(+2.0%) | $434.47 M(+4.5%) |
| Dec 2015 | $415.76 M(+10.7%) | $109.75 M(-3.2%) | $415.76 M(+4.3%) |
| Sept 2015 | - | $113.42 M(+14.2%) | $398.50 M(+5.2%) |
| June 2015 | - | $99.32 M(+6.5%) | $378.86 M(-4.0%) |
| Mar 2015 | - | $93.27 M(+0.8%) | $394.79 M(-3.7%) |
| Dec 2014 | $375.55 M(+13.1%) | $92.49 M(-1.4%) | $409.87 M(+19.3%) |
| Sept 2014 | - | $93.79 M(-18.6%) | $343.53 M(-1.7%) |
| June 2014 | - | $115.25 M(+6.4%) | $349.54 M(+3.5%) |
| Mar 2014 | - | $108.34 M(+314.2%) | $337.56 M(+1.6%) |
| Dec 2013 | $332.19 M(-11.0%) | $26.15 M(-73.8%) | $332.19 M(-17.5%) |
| Sept 2013 | - | $99.79 M(-3.4%) | $402.57 M(+1.7%) |
| June 2013 | - | $103.28 M(+0.3%) | $395.85 M(+1.8%) |
| Mar 2013 | - | $102.96 M(+6.7%) | $388.67 M(+4.2%) |
| Dec 2012 | $373.11 M(+4.2%) | $96.53 M(+3.7%) | $373.11 M(+0.5%) |
| Sept 2012 | - | $93.08 M(-3.1%) | $371.39 M(+1.5%) |
| June 2012 | - | $96.10 M(+9.9%) | $365.82 M(+0.1%) |
| Mar 2012 | - | $87.41 M(-7.8%) | $365.46 M(+2.0%) |
| Dec 2011 | $358.13 M(+17.4%) | $94.81 M(+8.3%) | $358.13 M(+3.5%) |
| Sept 2011 | - | $87.51 M(-8.6%) | $345.91 M(+3.5%) |
| June 2011 | - | $95.73 M(+19.5%) | $334.14 M(+6.9%) |
| Mar 2011 | - | $80.08 M(-3.0%) | $312.63 M(+2.5%) |
| Dec 2010 | $305.06 M | $82.59 M(+9.0%) | $305.06 M(+2.0%) |
| Sept 2010 | - | $75.74 M(+2.1%) | $298.95 M(+2.0%) |
| June 2010 | - | $74.22 M(+2.4%) | $293.13 M(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $72.51 M(-5.2%) | $287.16 M(+2.2%) |
| Dec 2009 | $281.10 M(+0.0%) | $76.48 M(+9.4%) | $281.10 M(+3.3%) |
| Sept 2009 | - | $69.92 M(+2.4%) | $271.99 M(-6.1%) |
| June 2009 | - | $68.25 M(+2.7%) | $289.74 M(+1.7%) |
| Mar 2009 | - | $66.45 M(-1.4%) | $284.96 M(+1.4%) |
| Dec 2008 | $281.00 M(+24.8%) | $67.37 M(-23.1%) | $281.00 M(+0.9%) |
| Sept 2008 | - | $87.66 M(+38.1%) | $278.49 M(+12.7%) |
| June 2008 | - | $63.48 M(+1.6%) | $247.07 M(+3.6%) |
| Mar 2008 | - | $62.49 M(-3.7%) | $238.57 M(+5.9%) |
| Dec 2007 | $225.19 M(+42.8%) | $64.86 M(+15.3%) | $225.19 M(+9.2%) |
| Sept 2007 | - | $56.24 M(+2.3%) | $206.26 M(+6.6%) |
| June 2007 | - | $54.98 M(+12.0%) | $193.45 M(+10.1%) |
| Mar 2007 | - | $49.10 M(+6.9%) | $175.69 M(+11.4%) |
| Dec 2006 | $157.71 M(+60.5%) | $45.94 M(+5.8%) | $157.71 M(+14.8%) |
| Sept 2006 | - | $43.43 M(+16.7%) | $137.43 M(+17.8%) |
| June 2006 | - | $37.22 M(+19.6%) | $116.66 M(+10.6%) |
| Mar 2006 | - | $31.12 M(+21.3%) | $105.48 M(+7.3%) |
| Dec 2005 | $98.27 M(-1.1%) | $25.66 M(+13.3%) | $98.27 M(+5.8%) |
| Sept 2005 | - | $22.65 M(-13.0%) | $92.87 M(-17.7%) |
| June 2005 | - | $26.04 M(+8.9%) | $112.82 M(+6.2%) |
| Mar 2005 | - | $23.92 M(+18.0%) | $106.27 M(+7.0%) |
| Dec 2004 | $99.36 M(+67.1%) | $20.26 M(-52.4%) | $99.36 M(+0.9%) |
| Sept 2004 | - | $42.60 M(+118.6%) | $98.45 M(+41.2%) |
| June 2004 | - | $19.49 M(+14.6%) | $69.73 M(+8.9%) |
| Mar 2004 | - | $17.01 M(-12.1%) | $64.06 M(+7.7%) |
| Dec 2003 | $59.46 M(+46.5%) | $19.36 M(+39.5%) | $59.46 M(+13.6%) |
| Sept 2003 | - | $13.88 M(+0.4%) | $52.33 M(+6.0%) |
| June 2003 | - | $13.82 M(+11.3%) | $49.36 M(+11.3%) |
| Mar 2003 | - | $12.41 M(+1.5%) | $44.36 M(+8.6%) |
| Dec 2002 | $40.59 M(+25.4%) | $12.22 M(+12.0%) | $40.84 M(+11.8%) |
| Sept 2002 | - | $10.91 M(+23.7%) | $36.54 M(+9.0%) |
| June 2002 | - | $8.82 M(-0.8%) | $33.53 M(+0.7%) |
| Mar 2002 | - | $8.89 M(+12.3%) | $33.30 M(+2.9%) |
| Dec 2001 | $32.37 M(-26.2%) | $7.92 M(+0.2%) | $32.37 M(-30.6%) |
| Sept 2001 | - | $7.91 M(-8.0%) | $46.62 M(+0.8%) |
| June 2001 | - | $8.59 M(+8.0%) | $46.26 M(+1.8%) |
| Mar 2001 | - | $7.96 M(-64.1%) | $45.46 M(+2.8%) |
| Dec 2000 | $43.85 M(+92.2%) | $22.17 M(+193.5%) | $44.20 M(+62.8%) |
| Sept 2000 | - | $7.55 M(-3.0%) | $27.15 M(+4.0%) |
| June 2000 | - | $7.79 M(+16.3%) | $26.09 M(+1.5%) |
| Mar 2000 | - | $6.70 M(+31.0%) | $25.71 M(+12.7%) |
| Dec 1999 | $22.81 M(+45.4%) | $5.11 M(-21.4%) | $22.81 M(+7.7%) |
| Sept 1999 | - | $6.50 M(-12.2%) | $21.19 M(+15.9%) |
| June 1999 | - | $7.40 M(+94.7%) | $18.29 M(+20.4%) |
| Mar 1999 | - | $3.80 M(+8.9%) | $15.19 M(-3.8%) |
| Dec 1998 | $15.69 M(-21.2%) | $3.49 M(-3.1%) | $15.79 M(-31.4%) |
| Sept 1998 | - | $3.60 M(-16.3%) | $23.00 M(-0.4%) |
| June 1998 | - | $4.30 M(-2.3%) | $23.10 M(+6.5%) |
| Mar 1998 | - | $4.40 M(-58.9%) | $21.70 M(+9.6%) |
| Dec 1997 | $19.90 M(+107.3%) | $10.70 M(+189.2%) | $19.80 M(+67.8%) |
| Sept 1997 | - | $3.70 M(+27.6%) | $11.80 M(+13.5%) |
| June 1997 | - | $2.90 M(+16.0%) | $10.40 M(+4.0%) |
| Mar 1997 | - | $2.50 M(-7.4%) | $10.00 M(+5.3%) |
| Dec 1996 | $9.60 M(+57.4%) | $2.70 M(+17.4%) | $9.50 M(+11.8%) |
| Sept 1996 | - | $2.30 M(-8.0%) | $8.50 M(+9.0%) |
| June 1996 | - | $2.50 M(+25.0%) | $7.80 M(+47.2%) |
| Mar 1996 | - | $2.00 M(+17.6%) | $5.30 M(+60.6%) |
| Dec 1995 | $6.10 M | $1.70 M(+6.3%) | $3.30 M(+106.3%) |
| Sept 1995 | - | $1.60 M | $1.60 M |
FAQ
- What is Integra LifeSciences Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual SG&A year-on-year change?
- What is Integra LifeSciences Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly SG&A year-on-year change?
- What is Integra LifeSciences Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM SG&A year-on-year change?
What is Integra LifeSciences Holdings annual selling, general & administrative expenses?
The current annual SG&A of IART is $656.64 M
What is the all time high annual SG&A for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual selling, general & administrative expenses is $690.75 M
What is Integra LifeSciences Holdings annual SG&A year-on-year change?
Over the past year, IART annual selling, general & administrative expenses has changed by +$40.33 M (+6.54%)
What is Integra LifeSciences Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of IART is $177.19 M
What is the all time high quarterly SG&A for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly selling, general & administrative expenses is $195.47 M
What is Integra LifeSciences Holdings quarterly SG&A year-on-year change?
Over the past year, IART quarterly selling, general & administrative expenses has changed by +$15.24 M (+9.41%)
What is Integra LifeSciences Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of IART is $3.74 B
What is the all time high TTM SG&A for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM selling, general & administrative expenses is $704.16 M
What is Integra LifeSciences Holdings TTM SG&A year-on-year change?
Over the past year, IART TTM selling, general & administrative expenses has changed by +$3.10 B (+479.78%)